Why GLP-1 side effects cluster after shot day — and when they ease
Ask a roomful of GLP-1 users when they feel queasy and you’ll hear the same answer with different words: “the day or two after my shot.” That consistency isn’t coincidence — it’s the medication’s curve at work.
The post-shot window
After a weekly injection, medication levels climb to a peak over roughly 1–3 days. GI side effects — nausea, and for some people vomiting or stomach upset — track that climb. In the published trials, these were the most commonly reported side effects: for example, ~44% of participants reported nausea at some point in STEP 1 (semaglutide 2.4 mg over 68 weeks), and about a quarter to a third in SURMOUNT-1 (tirzepatide), mostly during dose escalation.
Two encouraging details hide in that data:
- Side effects were mostly mild to moderate and concentrated in titration weeks — they typically fade as your body adapts to each dose step.
- “At some point during a 68–72 week trial” is very different from “every week”. Many participants had isolated episodes, not a weekly ordeal.
A week in phases
Map a typical week and the pattern becomes practical:
- Days 0–1 (absorption): levels rising. If you get queasy, it usually starts here. Light meals and hydration help many people.
- Days 1–3 (peak): strongest appetite suppression — and the window where GI symptoms cluster.
- Days 3–5 (steady): for most people, the easiest stretch.
- Days 6–7 (fading): the weekly trough. Appetite often returns; this is hunger-with-a-reason, not backsliding.
Knowing the phase changes how you plan: schedule the big dinner out for the steady phase, not day 1. Expect the day-7 appetite and have a plan for it.
Logging patterns worth showing your provider
“I get nauseous sometimes” is hard for a clinician to act on. “Nausea logged in 5 of my last 6 cycles, always days 1–2, easing by day 3, worse since the step-up to 1 mg” is genuinely useful — it distinguishes a normal titration pattern from something that needs attention.
That’s the logging style ShotLock is built around: quick daily check-ins that land on your cycle timeline, compared honestly against what trial participants reported — including telling you when you haven’t logged enough to compare.
When it’s not a pattern question
Persistent vomiting, signs of dehydration, severe abdominal pain, or anything that scares you isn’t a “wait for the steady phase” situation — contact your provider. Cycle awareness is for understanding the normal; it’s not a tool for triaging the abnormal.
General information, not medical advice. Trial figures are cited from published study reports and reflect trial populations, not predictions about you.